chartexchange

Kura Oncology Inc (KURA) (Q3 2026) Earnings Call Highlights: KOMZIFTI Revenue Surges 53% as ...

GuruFocus | Nov 11, 2026 2:08 AM EST

Kura Oncology Inc (KURA) posted $13.9 million in KOMZIFTI net product revenue with prescriptions up 65% and secured up to $300 million in financing to fund its expanding oncology pipeline. Related Stocks: KURA ,

Read original article